Kiora Pharmaceuticals' KIO-300 Shows Promise in Suppressing Seizure Activity in Preclinical Epilepsy Model

Kiora Pharmaceuticals reported that its ion channel modulator KIO-300 significantly reduced seizure-associated activity in an ex vivo temporal lobe ep...